All Research on Pharmaceutical Manufacturers in Europe

Insight

Brief
Brief

The Evolving Landscape in Biosimilars

Biosimilars offer significant opportunities, but only players with well-positioned offerings will see success in this challenging segment.

Published By Datamonitor
$1200
Buy
Case Studies
Case Studies

Transition at Teva: Blockbuster drug Copaxone to lose patent protection in 2014

This case study looks at Teva's operations and the market in which it operates, Copaxone, Teva's best-selling drug, and M&A activity Teva has been involved in over recent years, and whether or not it has been successful.

Published By MarketLine
$495
Buy
Case Studies
Case Studies

Orphan Drugs: Rescue from the patent cliff

Big Pharma has gone through some significant changes in recent years: many “blockbuster” drugs are losing their patents. In the orphan drugs market, where companies can charge high premiums for drugs which have little to no competition.

Published By MarketLine
$495
Buy

View all Insight >>

Profiles

Company Profile
Company Profile

Bayer AG

Bayer (or 'the group') is a Germany-based global chemical and pharmaceutical business group. It operates in Asia Pacific, Europe, North America, Latin America, Africa, and the Middle East. Bayer is headquartered in Leverkusen, Germany, and employed about 113,200 people as on December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Novo Nordisk A/S

Novo Nordisk (or 'the company') is a leading global provider of diabetes products. The company also has a leadership position in hemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk primarily operates in Europe, North America and Japan. It is headquartered in Bagsvaerd, Denmark, and employed 38,436 people as of December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Perrigo Company plc

Perrigo Company plc (Perrigo or 'the company'), formerly Perrigo Company Limited, is engaged in the development, manufacture and distribution of over-the-counter and generic prescription pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients, and medical diagnostic products. It also receives royalties on sales of Tysabri, a multiple sclerosis drug. The company primarily operates in the US, Israel, Mexico, Australia and the UK. It is headquartered...

Published By MarketLine
$175
Buy

View all Profiles >>

No help is available.